Search by Drug Name or NDC
NDC 00054-0283-25 Oxymorphone Hydrochloride 5 mg/1 Details
Oxymorphone Hydrochloride 5 mg/1
Oxymorphone Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is OXYMORPHONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Oxymorphone is used to relieve moderate to severe pain in people whose pain is not controlled with other medications. Oxymorphone is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the body responds to pain.
Related Packages: 00054-0283-25Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Oxymorphone
Product Information
| NDC | 00054-0283 |
|---|---|
| Product ID | 0054-0283_0e7efe87-54a9-4643-8ee7-d43f597941fe |
| Associated GPIs | 65100080100305 |
| GCN Sequence Number | 061086 |
| GCN Sequence Number Description | oxymorphone HCl TABLET 5 MG ORAL |
| HIC3 | H3A |
| HIC3 Description | OPIOID ANALGESICS |
| GCN | 27243 |
| HICL Sequence Number | 001696 |
| HICL Sequence Number Description | OXYMORPHONE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Oxymorphone Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | oxymorphone hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | OXYMORPHONE HYDROCHLORIDE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
| DEA Schedule | CII |
| Marketing Category | ANDA |
| Application Number | ANDA090964 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00054-0283-25 (00054028325)
| NDC Package Code | 0054-0283-25 |
|---|---|
| Billing NDC | 00054028325 |
| Package | 100 TABLET in 1 BOTTLE (0054-0283-25) |
| Marketing Start Date | 2010-09-27 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.52007 |
| Pricing Unit | EA |
| Effective Date | 2023-04-19 |
| NDC Description | OXYMORPHONE HCL 5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis